Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits
Authors
Keywords
NAFLD, Training, CB1 receptor, AMPK, FAS, CPT1
Journal
Lipids in Health and Disease
Volume 17, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-01
DOI
10.1186/s12944-018-0852-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
- (2018) Chun Kit Hung et al. Clinics in Liver Disease
- Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
- (2017) Sukhpreet Singh et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Polychlorinated biphenyls exposure-induced insulin resistance is mediated by lipid droplet enlargement through Fsp27
- (2016) Hye Young Kim et al. ARCHIVES OF TOXICOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Effect of Weight Loss on Magnetic Resonance Imaging Estimation of Liver Fat and Volume in Patients With Nonalcoholic Steatohepatitis
- (2015) Niraj S. Patel et al. Clinical Gastroenterology and Hepatology
- Simple Resistance Exercise helps Patients with Non-alcoholic Fatty Liver Disease
- (2015) A. Takahashi et al. INTERNATIONAL JOURNAL OF SPORTS MEDICINE
- Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
- (2013) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- The role of endocannabinoids system in fatty liver disease and therapeutic potentials
- (2013) KhalidA Alswat Saudi Journal of Gastroenterology
- Cannabinoid 1 receptor in fatty liver
- (2012) Simon Eringsmark Regnell HEPATOLOGY RESEARCH
- Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease
- (2011) Shelby Sullivan et al. HEPATOLOGY
- Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice
- (2011) Marisa JS Frederico et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Role of Cannabinoids in the Development of Fatty Liver (Steatosis)
- (2010) Vishnudutt Purohit et al. AAPS Journal
- CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
- (2010) T. Jourdan et al. DIABETES
- Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis
- (2009) A. Mallat et al. DIABETES & METABOLISM
- Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis
- (2009) David R Janero et al. EXPERT OPINION ON EMERGING DRUGS
- Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss
- (2009) Nathan A. Johnson et al. HEPATOLOGY
- Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver
- (2008) Won-il Jeong et al. Cell Metabolism
- Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study †
- (2008) Luc F. Van Gaal et al. EUROPEAN HEART JOURNAL
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
- (2008) Douglas Osei-Hyiaman et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started